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INTRODUCTION
Tooth avulsion, characterized by complete dis-
placement of the tooth from the socket, accounts for 
nearly 0.5 to 16% of all dental trauma cases (1). Several 
tissues may be affected or damaged by tooth avulsion, 
including the periodontal ligament, alveolar bone, gin-
giva, lips and dental pulp (1). The periodontal ligament 
is disrupted and has its arrangement disorganized and 
its viability affected (1,2). The vascular-nerve bundle 
that supplies the dental pulp is also disrupted, leading to 
pulp necrosis in most cases (1). Tooth avulsion is thus as 
a complex traumatic injury with difficult treatment (2).
After avulsion, the tooth should be repositioned 
in the socket in an attempt to reestablish the normality 
(1). The success of tooth replantation depends on the 
maintenance of vitality of the cells present on root surface 
(1). Hence, immediate replantation (1,3) or storage of 
avulsed teeth in adequate medium to allow survival of 
these cells until replantation (1) is fundamental.
Studies with different populations reveal an over-
all lack of knowledge on what should be done in cases 
of tooth avulsion (4,5). Instead of performing immediate 
replantation or storing the tooth in adequate medium, 
people usually let the tooth dry, keeping it wrapped in 
plastic or paper; or sometimes store the tooth immersed 
in solutions that do not allow for cell survival. This may 
lead to ankylosis and root resorption, both undesirable 
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consequences of tooth replantation (1,2).
In an attempt to prevent or limit the root resorp-
tion and promote repair of the area, in case of late re-
plantation, the tooth should be submitted to root surface 
treatment and endodontic therapy (1,2). Currently, root 
surface treatment is done with sodium hypochlorite, 
which removes the root-adhered necrotic remnants 
without affecting the cementum layer (2,6). Fluoride is 
applied because it strengthens the tooth structure by the 
formation of fluorapatite, and also because it is toxic to 
resorptive cells (2,6,7). Calcium hydroxide is generally 
accepted as the intracanal medication of choice (7,8) due 
to its antimicrobial and anti-resorptive characteristics.
Nevertheless, despite these clinical procedures, 
treatment failure and tooth resorption are not uncommon 
events. Teeth are ultimately lost after 4 to 6 years on 
average (9). Thus, the search for new substances that 
may inhibit or delay the effects of root resorption and 
promote repair is fundamental. 
Mori et al. (2) previously reported that the use of 
a 10-5 M acetazolamide (AZ) solution as an intracanal 
medication was able to inhibit root resorption in cases of 
delayed tooth replantation. AZ was more efficient than 
calcium hydroxide. However, due its liquid presentation, 
the insertion and retention of AZ inside the root canal 
are challenging. The development of AZ pastes would 
enhance its use as an intracanal medication in teeth 
susceptible to root resorption. Ideally, the experimental 
AZ pastes should be biocompatible with the surrounding 
tissues, since the concentration of AZ in pastes is higher 
than that in solution (2). Pastes should be further tested 
in replanted teeth regarding its effectiveness to inhibit 
root resorption. 
This study evaluated the biocompatibility of two 
experimental AZ-based pastes in rat subcutaneous tissue.
MATERIAL AND METHODS
Two experimental AZ pastes were tested, oth 
containing AZ (Deg Produtos Químicos Ltda, CAS 59-
66-5, São Paulo, SP, Brazil) as the main component in 
similar concentrations. Saline (Drogaderma, Presidente 
Prudente, SP, Brazil) and propylene glycol (Drogaderma) 
were the vehicles in experimental paste 1 (EP1) and 
experimental paste 2 (EP2).
The study was conducted on 15 male rats (Rattus, 
norvegicus, albinus, Wistar) weighing 180-200 g. All 
experimental procedures were approved by the Animal 
Ethics Research Committee of Bauru Dental School, 
University of São Paulo, Brazil (Process 08/2006). The 
rats were housed in cages cleaned daily and labeled ac-
cording to the groups and study periods. The animals 
received and water ad libitum and solid food before and 
during the study, except for the 12 h pre-surgery.
The animals were anesthetized with an intra-
muscular injection of ketamine hydrochloride (Dopalen 
Sespo Indústria e Comércio Ltda, Jacareí, SP, Brazil) 
and xylazine hydrochloride (Anasedan Agribrands 
do Brasil Ltda., Jacareí, SP, Brazil), at a dose of 0.05 
mL/100 g body weight per drug. Thereafter, 60 sterile 
polyethylene tubes (1.3 mm of internal diameter and 
10 mm long) were sealed at one end with gutta-percha 
(GP) (Odahcam Dentsply Indústria e Comércio Ltda., 
Petrópolis, RJ, Brazil) and were filled with EP1 (n=30) 
or EP2 (n=30), using a sterile lentulo spiral (Dentsply/
Maillefer, Ballaigues, Switzerland).The tube ends sealed 
with GP were used as a control group.
Prior to subcutaneous implantation of the tubes, 
the animals had the dorsal region shaved and cleaned 
with 0.12% chlorhexidine gluconate (PerioGard®; Pfizer 
Ltda, São Paulo, SP, Brazil). Two surgical incisions 
were done in the median region with a size 15 blade. 
Laterally to the incisions, the cutaneous tissue was 
reflected,  gentle dissection was done with blunt-ended 
scissors and the tubes were implanted in the subcutane-
ous tissue. In each animal, 2 tubes containing EP 1 were 
placed in the scapular region and 2 tubes containing EP 
2 were placed in the pelvic region. The incisions were 
sutured using nylon 4-0 (Ethicon Johnson & Johnson, 
São Paulo, SP, Brazil).
After 7, 15, and 45 days, 5 animals of experimen-
tal each group (EP1 and EP2) were killed by anesthetic 
overdose. The tissues containing the tubes were removed, 
fixed in 10% formalin for 48 h and then the tubes were 
explanted. The tubes were examined to ensure that both 
AZ paste and GP were still present. The specimens were 
embedded in paraffin for histological processing. Longi-
tudinal 5 mm-thick sections were cut at 50 mm  intervals, 
totalizing 15 sections per specimen. The sections were 
stained with hematoxylin and eosin and analyzed by 
light microscopy regarding the presence or absence of 
inflammation. When present, the type of inflammatory 
cells, intensity of the inflammatory response and its 
relationship with the materials were also evaluated. The 
occurrence of destructive processes, such as abscesses 
and tissue necrosis, were also considered. Tissue prolif-
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eration was also recorded when present. The biocompat-
ibility of the experimental paste with the surrounding 
tissues was classified according to scores, varying with 
the intensity of inflammation. The following 4-point 
scoring system was used to determine the intensity of 
the inflammatory response in rat subcutaneous tissue: 
1= absent, 2 = mild, 3 = moderate, and 4 = severe. The 
criteria for classification of the intensities of inflamma-
tion and tissue reactions were established according to 
recommended standard practices for biological evalua-
tion of dental materials (10). The scores were assigned 
by a blinded and experienced examiner. The histological 
sections were not identified and the scores were recorded 
on specific tables. Statistical analysis of the results was 
done by the Kruskal-Wallis test (a=0.05).
RESULTS
Experimental Paste 1
At 7 days, histological sections exhibited collagen 
fibers and few fibroblasts. An inflammatory process 
was present in most sections, being predominantly mild 
(score 2) and moderate to severe (scores 3 and 4) in some 
cases. Neutrophils were the most frequent inflammatory 
cells. At 15 days, there was regression of inflammation, 
which was absent in most sections (score 1). In some 
sections, few lymphocytes and macrophages (score 2) 
were found. Connective tissue with collagen fibers, 
fibroblasts and blood vessels were present at 15 days. 
At 45 days, a well-organized connective tissue with tis-
sue ingrowth into the tube was observed in some cases. 
Inflammation was absent in all sections at 45 days (score 
1) (Fig. 1), except for 2 sections, which exhibited mild 
inflammatory process with few lymphocytes (score 2). 
Experimental Paste 2
At 7 days, the histological sections exhibited 
severe inflammatory process with neutrophils in all 
specimens and areas of abscess in most sections (scores 3 
and 4). At 15 days, collagen fibers, fibroblasts and great 
blood vessel proliferation were seen. Inflammation was 
severe to moderate in most sections at 15 days (score 
3). At 45 days, most sections exhibited  inflammation 
of mild to moderate intensity (scores 2 and 3) (Fig. 2).
Control
The microscopic analysis of histological sections 
confirmed the biocompatibility of GP with the connec-
tive tissue (Fig. 3). There was absence of inflammatory 
process at all study periods (score 1). Only 3 sections, 
namely two at 7 days and one at 15 days, exhibited mild 
inflammatory infiltrate (score 2). At 7 days, there were 
poorly organized collagen fibers and fibroblasts. At 15 
and 45 days, the connective tissue was well organized, 
with collagen fibers, fibroblasts and blood vessels.
Figure 1. Experimental paste 1 (45 days). Presence of organized 
connective tissue with proliferation of blood vessels and absence 
of inflammatory process (Original magnification ×157.5).
Figure 2. Experimental paste 2 (45 days). Presence of inflammatory 
process, large amount of neutrophils and intense proliferation of 
blood vessels (Original magnification ×157.5).
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Statistical Results
The results showed no statistically significant 
differences between GP (control) and EP 1 (p>0.05). 
However, EP 2 differed significantly from GP (control) 
and from EP 1 (p≤0.05) (Table 1).
DISCUSSION
The guidelines suggested by the American Dental 
Association (11) and Fédération Dentaire Internationale 
(12) consider implantation methods as valid tests to in-
vestigate the biocompatibility of materials. Implantation 
of materials in the connective tissue of small animals, 
such as rata, is considered an adequate method to evaluate 
their biocompatibility. A biocompatible material should 
present low toxicity, with promotion of no or insignificant 
inflammatory response (10,13). In implantation tests, the 
new material should be compared to a control one, which 
should be an acknowledged nontoxic material (14). GP 
is considered to have acceptable biocompatibility with 
no or low degree of toxicity (13), being thus used as a 
parameter to evaluate toxicity of the experimental pastes 
in the present study.
AZ is known as a potent inhibitor of carbonic an-
hydrase (15,16), an enzyme present in clasts. This enzyme 
catalyses the reaction between carbonic acid and water, 
resulting in the formation of hydrogen ions (1,17,18), which 
in turn are responsible for the decrease in pH in Howship 
lacunae (9,17,18). The acidic pH allows release and action of 
other enzymes that will participate in the resorption process 
(18). Therefore, if carbonic anhydrase is inhibited, there 
will be no pH drop and resorption is not likely to occur. 
Several studies have confirmed the efficacy of AZ in 
inhibiting bone resorption (15,16). The idea of using AZ as 
a substance to inhibit root resorption was presented by Mori 
and Garcia in 2002 (6). Briefly, an AZ solution was used 
for the treatment of root surfaces of rat teeth that had been 
intentionally avulsed and submitted to delayed replantation. 
The results demonstrated the occurrence of root resorption, 
contraindicating its use. So, the hypothesis of using AZ as 
an intracanal therapeutic agent was recommended. Mori 
et al. (2) demonstrated the efficiency of an AZ solution as 
an intracanal therapeutic agent in inhibiting root resorption 
in late reimplanted rat teeth. The development of an AZ 
paste would enhance its use as an intracanal medication 
in teeth susceptible to root resorption. This is the reason 
why, in this study, we investigated the biocompatibility of 
2 experimental AZ pastes. The pastes used in this work 
had AZ as main component. In paste 1, saline was used as 
vehicle and paste 2 was prepared with propylene glycol. 
Saline was selected due to is biocompatibility (19), ease of 
handling and lack of effect on the properties of the active 
ingredient (15). Propylene glycol was selected because 
of its good consistency, viscosity, ease of handling, high 
quality and antimicrobial capacity (20). 
According to the results of the present study, EP 1 
was biocompatible with the surrounding tissues. Although 
an inflammatory response was observed at 7 days, the 
inflammation was nearly absent in the subsequent study 
periods. Moreover, there was no statistically significant 
difference between the results of this experimental paste 
and those of GP (control).
Figure 3. Control (45 days). Presence of organized connective 
tissue with proliferation of blood vessels and absence of 
inflammatory process (Original magnification ×157.5).
Table 1. Mean scores recorded for each group at each period.
Groups
Study periods
7 days 15 days 45 days
Paste 1 (AZ + saline) 2.4a 1.3b 1.3b
Paste 2 (AZ +
propylene glycol) 3.6c 3.0c 2.5c
Control (GP) 1.3d 1.1d 1.0d
Different letters indicate statistically significant difference at 5%.
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As reported by Waite et al. (15), AZ may be mixed 
with saline, which does not alter the properties of the active 
substance. Thus, EP1 may be considered satisfactory for use 
as an intracanal medication. Studies on teeth susceptible to 
root resorption should be conducted to confirm its efficacy. 
Unlike EP 1,  EP 2 cannot be considered a biocompatible 
material, as inflammation was present at all study periods. 
Although the inflammatory response was less severe at 45 
days compared to the earlier periods, it was more intense 
than that observed in the control group. The difference 
between the experimental pastes may be related to differ-
ences in vehicle used in their preparation. 
In summary, EP1 (AZ + saline) was found to be bio-
compatible, showing similar results as those of the control 
material (GP), and may be considered a viable alternative 
for use as an intracanal medication. Further research on 
teeth susceptible to root resorption should also be performed 
to confirm its clinical application. However, EP 2 (AZ + 
propylene glycol) was irritating to the subcutaneous tissue 
of rats and thus its use should be contraindicated.
RESUMO
Este estudo investigou a biocompatibilidade de pastas experi-
mentais a base de acetazolamida em tecido subcutâneo de rato. 
Duas pastas foram usadas neste estudo. Ambas continham a 
acetalozamida como componente principal em concentrações 
similares. O veículo usado na pasta experimental 1 foi o soro 
fisiológico e na pasta experimental 2 foi o propilenoglicol. Ses-
senta tubos de polietileno foram selados em uma das extremidades 
com guta-percha, que serviu como controle. Metade dos tubos 
foi preenchida com a pasta 1 e metade com a pasta 2. Os tubos 
foram introduzidos no tecido subcutâneo de 15 ratos (4 tubos por 
animal). Aos 7, 15 e 45 dias após a cirurgia, os animais foram 
sacrificados e os espécimes processados em laboratório. Os 
cortes histológicos foram corados com hematoxilina e eosina e 
analisados em microscópio de luz. Escores foram estabelecidos 
de acordo com a intensidade do processo inflamatório: 1-sem 
inflamação; 2-discreta; 3-moderada; 4-severa. Os dados obtidos 
foram comparados estatisticamente através do teste de Kruskal-
Wallis (p≤0,05). A pasta 1 promoveu processo inflamatório aos 7 
dias. Entretanto, sua intensidade diminuiu com o tempo e estava 
praticamente ausente aos 45 dias. Não foi observada diferença 
estatisticamente significante entre o controle (guta-percha) e a 
pasta 1. Entretanto, a pasta 2 promoveu reação inflamatória em 
todos os períodos experimentais, com  diferença estatisticamente 
significante em relação ao controle. Assim, a pasta experimental 
de acetazolamida 1 foi considerada biocompatível como o controle 
deste trabalho. Já a pasta experimental 2 foi irritante aos tecidos. 
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